Area of Research: Therapeutic Targeting
2022 Grant Recipients
-
Jasmine Plummer, PhD,
Cedars-Sinai Medical Center
Early Career Investigator GrantChemopreventative Targets in BRCA1 Carrier Models with P53 Lesions (Gail Baird Foundation Research Grant Recipient)
-
Ronald Buckanovich, MD, PhD,
Magee-Womens Research Institute
Collaborative Research Development GrantRole of Macrophage-secreted BIGH3 in Tumor Immunity
-
Imade Williams, PhD,
Indiana University
Mentored Investigator GrantTargeting MYC-HSF1 co-Amplification in High Grade Serous Ovarian Cancer
-
Gamze Bildik Elcik, PhD,
MD Anderson Cancer Center
Mentored Investigator GrantDIRAS3 Inhibits KRAS and Sensitizes LGSOC Cells to Anti-autophagic Therapy
2019 Grant Recipients
-
Isaac Klein, MD, PhD,
Dana Farber Cancer Institute
Mentored Investigator GrantTranscriptional Regulatory Landscape of High Grade Serous Ovarian Cancer
-
Xiaowen Hu, PhD,
University of Pennsylvania
Early Career Investigator GrantTargeting Chromatin Remodeling Complex to Treat Ovarian Cancer
-
Kate Lawrenson, PhD,
Cedars-Sinai Medical Center
Early Career Investigator GrantElucidating the Role of SOX17 in HGSOC
-
Ronald Buckanovich, MD, PhD,
Magee-Womens Research Institute
Collaborative Research Development GrantTargeting Tumor Desmoplasia to Enhance Immunotherapy
2017 Grant Recipients
-
Nabanita Chatterjee, PhD,
MD Anderson Cancer Center
Mentored Investigator GrantOvarian Cancer Disrupts Circadian Cortisol Rhythms
-
Jagmohan Hooda, PhD,
University of Pennsylvania
Mentored Investigator GrantLoss of H2Bub1 Rewires Glutamine Metabolism During Progression of HGSOC
-
Dongyu Jia, PhD,
Cedars-Sinai Medical Center
Mentored Investigator GrantCOL11A Is A Highly Specific Therapeutic Target in Cancer-Activated Stroma
-
Ronen Marmorstein, PhD,
University of Pennsylvania
Collaborative Research Development GrantChromatin Regulatory Mechanisms in Ovarian Cancer
2016 Grant Recipients
-
Fan Zhao, PhD,
Stanford University
Mentored Investigator GrantOvarian Cancer Antigen Discovery by Single t-cell Analysis and pHLA Library
2015 Grant Recipients
-
Alfredo Perales-Puchalt, MD,
The Wistar Institute
Mentored Investigator GrantTargeting FSH Receptor with Chimeric Antigen Receptor in Ovarian Cancer
2014 Grant Recipients
-
Rachel Grisham, MD,
Memorial Sloan Kettering Cancer Center
Early Career Investigator GrantDetermining the Molecular Drivers of Low-Grade Serous Ovarian Cancer
-
Selvendiran Karuppaiyah, PhD,
Ohio State University
Early Career Investigator GrantNew Type of Experimental Drug for Ovarian Cancer
-
Ilana Chefetz, PhD,
University of Michigan
Mentored Investigator GrantA Role for ALDH in the Regulation of Necroptosis in Ovarian Cancer Area of research: Therapeutic Targeting
-
Kyung Hee Noh, PhD,
MD Anderson Cancer Center
Mentored Investigator GrantTargeting Adaptive Changes to anti-VEGF Therapy in Ovarian Cancer
-
Shailja Pathania, PhD,
Dana Farber Cancer Institute
Mentored Investigator GrantNovel Therapeutic Targets for High-Grade Serous Ovarian Carcinoma
2013 Grant Recipients
-
Maria Barbolina, PhD,
University of Illinois - Chicago
Early Career Investigator GrantChemokine-Dependent Control of Survival in Ovarian Carcinoma
-
Stephanie Gaillard, MD, PhD,
Duke Cancer Institute
Early Career Investigator GrantEvaluating ERRalpha as a Novel Therapeutic Target in Ovarian Cancer
-
Teng Ma, MD, PhD,
University of Michigan - Ann Arbor
Mentored Investigator GrantThe Analysis of NEDD8-activating Enzyme Inhibitor MLN4924 on Ovarian Cancer
-
Xin Huang, PhD,
Magee-Womens Research Institute
Early Career Investigator GrantNoval Strategy of Metabolic Targeting Ovarian Cancer: Focusing on the Tumor Hypoxia Pathway
-
Mythreye Karthikeyan, PhD,
University of South Carolina
Early Career Investigator GrantInvestigating the TGFß Superfamily as Therapeutic Targets in Ovarian Cancer
-
Joyce Liu, MD, MPH,
Dana Farber Cancer Institute
Early Career Investigator GrantInvestigating ErbB3 as a Novel Therapeutic Target in Ovarian Cancer
-
Yin Wang, PhD,
Mayo Clinic Jacksonville
Mentored Investigator GrantProtein Kinase C iota is a Novel Therapeutic Target for Ovarian Cancer Treatment
2012 Grant Recipients
-
Bin Guan, PhD,
Johns Hopkins University School of Medicine
Mentored Investigator GrantFunctional Characterization of the Tumor Suppressor ARID1A in Ovarian Cancer
-
Karen Cowden Dahl, PhD,
Indiana University
Early Career Investigator GrantInvestigation of ARID3B Splicing as a Novel Therapeutic Target for Ovarian Cancer
-
Hanqing Liu, PhD,
Fox Chase Cancer Center
Mentored Investigator GrantTargeting Signaling Networks via RNAi to Improve Therapy for Ovarian Cancer
-
W. Ruprecht Wiedemeyer, PhD,
Cedars-Sinai Medical Center
Early Career Investigator GrantOvarian Cancer Evolution After Targeted Therapy
2011 Grant Recipients
-
Santo Nicosia, MD,
University South Florida
Collaborative Research Development GrantOvarian Cancer: A Theme Based Approach Toward Identification of Novel Diagnostic and Therapeutic Targets
-
Sherry Wu, PhD,
MD Anderson Cancer Center
Mentored Investigator GrantNovel Approach to Destroy the Blood Supply that Feeds Ovarian Cancer Tumors
-
Selvendiran Karuppaiyah, PhD,
Ohio State University
Early Career Investigator GrantSafe, Targeted, Antitumor Therapeutics (STAT3 Inhibitors) for Ovarian Cancer
2008 Grant Recipients
-
Takayo Ota, MD, PhD,
Mayo Clinic Rochester
Mentored Investigator GrantCharacterizing the Genetic Alterations of Aggressive Ovarian Cancer
-
Thuy-Vy Do, PhD,
Fox Chase Cancer Center
Mentored Investigator GrantUnderstanding How Ovarian Cancer Spreads
2007 Grant Recipients
-
Martin Matthew Matzuk, MD, PhD,
Baylor College of Medicine
Collaborative Research Development GrantMicroRNA’s as Diagnostic and Therapeutic Targets in Ovarian Cancer
-
Mitchell Cheung, PhD,
Fox Chase Cancer Center
Mentored Investigator GrantTesting New Therapeutic Agents to Treat Ovarian Cancer
2005 Grant Recipients
-
Anil K. Sood, MD,
MD Anderson Cancer Center
Collaborative Research Development GrantNovel siRNA Based Therapeutic Approaches for Ovarian Carcinoma
-
Andrew K. Godwin, PhD,
Fox Chase Cancer Center
Collaborative Research Development GrantTherapeutic Targeting of the Tumor Microenvironment in Ovarian Cancer
2004 Grant Recipients
-
Ernst Lengyel, MD, PhD,
University of Chicago
Early Career Investigator GrantRole and Regulation of Hepatocyte Growth Factor and c-Met in Ovarian Cancer
2001 Grant Recipients
-
Kimberly Kalli, PhD,
Mayo Clinic
Early Career Investigator GrantFunctional Significance of Insulin Receptors in Epithelial Ovarian Cancer: Therapeutic Implications